BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18622185)

  • 1. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
    Santos CJ; Stern CA; Bertoglio LJ
    Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M; Zarrindast MR; Bina P
    Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.
    Aguiar DC; Terzian AL; Guimarães FS; Moreira FA
    Psychopharmacology (Berl); 2009 Aug; 205(2):217-25. PubMed ID: 19387617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
    Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
    Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
    Zarrindast MR; Babapoor-Farrokhran S; Babapoor-Farrokhran S; Rezayof A
    Life Sci; 2008 Jun; 82(23-24):1175-81. PubMed ID: 18456284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory.
    Li HB; Mao RR; Zhang JC; Yang Y; Cao J; Xu L
    Biol Psychiatry; 2008 Aug; 64(4):286-92. PubMed ID: 18405883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.
    Engin E; Treit D
    Neuropeptides; 2008 Aug; 42(4):411-21. PubMed ID: 18508119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats.
    Nascimento Häckl LP; Carobrez AP
    Neurobiol Learn Mem; 2007 Sep; 88(2):177-85. PubMed ID: 17540583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential vanilloid 1 channels modulate the anxiolytic effect of diazepam.
    Manna SS; Umathe SN
    Brain Res; 2011 Nov; 1425():75-82. PubMed ID: 22018687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
    Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
    Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of TRPV1 channels in the periaqueductal grey on the modulation of innate fear responses.
    Aguiar DC; Almeida-Santos AF; Moreira FA; Guimarães FS
    Acta Neuropsychiatr; 2015 Apr; 27(2):97-105. PubMed ID: 25529842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours.
    Rostami P; Hajizadeh-Moghaddam A; Zarrindast MR
    Physiol Behav; 2006 May; 87(5):891-6. PubMed ID: 16600315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
    Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.
    Athanasiou A; Smith PA; Vakilpour S; Kumaran NM; Turner AE; Bagiokou D; Layfield R; Ray DE; Westwell AD; Alexander SP; Kendall DA; Lobo DN; Watson SA; Lophatanon A; Muir KA; Guo DA; Bates TE
    Biochem Biophys Res Commun; 2007 Mar; 354(1):50-5. PubMed ID: 17214968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
    Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
    Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient receptor potential vanilloid type 1 receptor regulates glutamatergic synaptic inputs to the spinothalamic tract neurons of the spinal cord deep dorsal horn.
    Kim H; Cui L; Kim J; Kim SJ
    Neuroscience; 2009 May; 160(2):508-16. PubMed ID: 19236908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors.
    Kasckow JW; Mulchahey JJ; Geracioti TD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):291-5. PubMed ID: 14751425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals.
    Köfalvi A; Oliveira CR; Cunha RA
    Neurosci Lett; 2006 Jul; 403(1-2):151-6. PubMed ID: 16672175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.